Celecoxib Active Pharmaceutical Ingredient from China
Celecoxib is a selective COX-2 inhibitor used in nonsteroidal anti-inflammatory drugs for pain relief and arthritis treatment. It contains an unfused pyrazole ring in its aromatic heterocyclic structure, classifying it under HTS 2933.19.3500 as a drug. This API is imported for pharmaceutical formulation.
Duty Rate — China → United States
31.5%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Provide FDA Drug Master File (DMF) and Certificate of Analysis confirming pyrazole structure and purity >99%
• Ensure DEA registration if precursor potential exists; include pharmacopeial compliance certificates
• Avoid misclassification as research chemical by providing end-use affidavits for pharmaceutical production